Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years
Over the last three decades, the decriminalization and legalization of therapeutic and recreational marijuana consumption have increased. Consequently, the availability of marijuana-based products associated with its therapeutic use has increased. These developments have stimulated research on canna...
Saved in:
| Main Authors: | Marcel Pérez-Morales, Rodolfo Espinoza-Abad, Fabio García-García |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/2/266 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CB1 receptor and psychosis: friend, foe, or both
by: Jagadeesh S. Rao, et al.
Published: (2025-07-01) -
CC48 a new CB2R agonist/FAAH inhibitor dual drug blocks gastric cancer progression and overcomes paclitaxel resistance
by: Annalisa Schirizzi, et al.
Published: (2025-07-01) -
Paeoniflorin inhibits APEC-induced inflammation in HD11 cells through the NF-κB signaling pathway by activating CB2R
by: Siyang Shen, et al.
Published: (2025-02-01) -
Synergistic Effect of MWCNT and CB on the Piezoresistive Properties of Laser Ablation Composites Strain Sensors
by: Shikang Yin, et al.
Published: (2025-06-01) -
Cannabidiol as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function
by: Iu Raïch, et al.
Published: (2025-05-01)